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1002-98 Platelet-Derived Growth Factor Signaling Has a Crucial 
Role in Vascular Maturation Following Myocardial 
Infarction
Pawel T. Zymek, Kamal Nasser, Sophia Tincey, Guofeng Ren, Marcin Dobaczewski, 
Lloyd H. Michael, Mark L. Entman, Nikolaos G. Frangogiannis, Baylor College of 
Medicine, Houston, TX
Background: During the maturation phase of healing, infarct microvessels are coated by
pericytes, whereas uncoated vessels regress. Acquisition of a muscular coat leads to for-
mation of a mature vasculature preventing uncontrolled angiogenesis and decreasing
leukocyte extravasation. Platelet Derived Growth Factor (PDGF) is crucial for coating of
developing fetal vessels with pericytes. Accordingly, we examined the role of PDGF in
maturation of infarct neovessels.
Methods: A canine and a murine model of reperfused infarction were used. In vitro exper-
iments examined the effects of PDGF stimulation on isolated canine endothelial cells. To
study the role of PDGF in infarct healing, mice undergoing infarction protocols were
injected daily with neutralizing anti-PDGF antibody, or vehicle and were sacrificed after 7
days of reperfusion.
Results: Canine infarcts showed a progressive increase in the number of pericyte-coated
vessels after 2-4 weeks of reperfusion. In murine infarcts the healing rate is faster and
maturation of the vasculature occurred after 7 days of reperfusion. PDGF expression was
localized in infarct microvessels, whereas many PDGF Receptor b expressing pericytes
were identified in dog infarcts after 5-14 days and in mouse infarcts after 3-7 days of rep-
erfusion. PDGF neutralization induced significant morphological alterations of the infarct
microvasculature leading to formation of a higher number of large uncoated vessels
(p<0.05) and a lower capillary density. Uncoated vessels in PDGF antibody-treated ani-
mals were dilated and irregular and were associated with areas of red blood cell and
inflammatory leukocyte extravasation, suggesting increased permeability. PDGF-stimu-
lated endothelial cells had increased expression of the extracellular matrix cross-linking
enzyme tissue transglutaminase, supporting a role for PDGF in endothelial basement
membrane stabilization.
Conclusions: PDGF expression in healing infarcts has a critical role in vascular coating
and maturation and is important for stabilization of the scar. PDGF inhibition leads to for-
mation of a chaotic hyperpermeable vasculature and results in prolonged extravasation
of blood cells into the infarct.
1002-99 Interleukin Converting Enzyme Inhibition Reduces 
Endoplasmic Reticulum (ER) Stress and Attenuates ER 
Stress Associated Death Signals in Ventricular 
Myocardium From Post Myocardial Infarction Rats
Y. Chandrashekhar, Ruth Anway, Soma Sen, Inder Anand, VAMC/University of 
Minnesota, Minneapolis, MN
Background: Ischemia or cytokines cause Endoplasmic Reticulum (ER) stress which trig-
gers the Unfolded Protein Response (UPR). Prolonged UPR mediates cell death. It is not
clear if this happens during heart failure (HF).
Hypothesis: Since cytokine activation is common in HF, UPR & UPR mediated death sig-
nals should be active in the failing myocardium. Interleukin converting enzyme (ICE) is
important for cytokine maturation & ICE inhibition [ICE-I] might thus reduce UPR & atten-
uate apoptosis.
Methods: We measured cytoplasmic Bip/GRP78 (a marker for ER stress), ERP57 (which
reduces ER stress) & CHOP (which initiates apoptotic signaling specifically after ER
stress) levels (western blot) in rats with MI given ICE-I, [zAsp-DCB, 1 mg/day x 30, n=12]
or vehicle [V] (n=9). This was correlated with cytochrome C release, apoptosis & ventric-
ular remodeling (Echo & Hemodynamics).
Results: Infarcts were 35±6% & comparable in both groups. Bip & CHOP levels were
high in [V] compared to sham suggesting chronically activated UPR & increased apop-
totic signaling. ICE-I significantly reduced myocardial Bip & CHOP levels & improved
ERP 57. ICE-I also reduced cytochrome C release, attenuated apoptosis and was asso-
ciated with improved LV remodeling & systolic function.
Conclusions: We show for the first time, that the failing heart manifests ER stress & UPR
associated death signaling. This could worsen remodeling. ICE-I reduces these adverse
events & attenuates apoptosis. ICE-I may have important therapeutic implications.
1002-100 Tyrosine Kinase-Dependent Mechanism Occurs 
Downstream of Protein Kinase C Activation in the 
Pharmacological Preconditioning by Alpha-1 
Adrenoceptor Stimulation
Shinji Okubo, Yujirou Tanabe, Ryoko Satho, Yachiyo Hoshiba, Kenji Takeda, Michihiko 
Kitayama, Seiyu Kanemitsu, Hiroichi Tsugawa, Noboru Takekoshi, Kanazawa Medical 
University, Uchinada, Japan
Recent evidence suggests that alpha-adrenergic receptor activation induced cardiopro-
tection via protein kinase C (PKC)-sensitive pathway. We hypothesized that tyrosine
phosphorylation may be involved in the cardioprotection induced by activation of alpha-
adrenergic receptor. All rabbits were subjected to regional ischemia by 30 minutes LAD
occlusion followed by 3 hours of reperfusion. Risk area (RA) was determined by injection
of 50% Unisperse blue and infarct size (IS) was determined by computer morphometry of
tetrazolium stained sections. Infarct size was expressed as a percent of area risk (%IS/
AR).IS reduced significantly from 42±2 % in the control to 24±2 % in a alpha-adrenergic
receptor agonist, phenylephrine (25 µg/kg i.v )-treated rabbits (p<0.01). IS limitation by
phenylephrine was completely abolished by a PKC inhibitor, chelerythrine (5mg/kg, i.v;
%IS/AR, 49 ± 4) or non-specific tyrosine kinase (TK) inhibitor, genistein (5mg/kg, i.v;
%IS/AR, 46±5 ). Similarly, IS limitation by phenylephrine was completely blocked by spe-
cific TK inhibitor, lavendustin A (1 mg/kg, i.v; %IS/AR, 49±3). On the other hand, the car-
dioprotection (%IS/AR, 20 ± 3 ) by a combined injection of phenylephrine and PKC
activator, 4β-phorbol 12-myristate 13-acetate (PMA:4µg/kg, i.v ) was shown significantly
(p<0.01) . However, this cardioprotection was abolished by genistein (%IS/AR, 45 ± 4) or
lavendustin A (%IS/AR, 47± 5). On the other hand, an inactive structural analog of
genistein, daidzein (5mg/kg, i.v) did not attenuate the IS limitation by phenylephrine
(%IS/AR, 22 ± 3) or a combined injection of phenylephrine and PMA (%IS/AR, 20 ± 5). In
contrast, IS limitation effect by phenylephrine was completely abolished by a combined
injection of chelerythrine and daidzein (%IS/AR, 48 ± 3). These results suggested that
alpha-adrenergic receptor stimulation limits infarct size by a tyrosine phosphorylation
sensitive mechanism and TK plays as downstream element of PKC-mediated signal
transduction in the rabbit heart.
1002-101 Pyrroloquinoline Quinone Decreases Myocardial Infarct 
Size and Improves Cardiac Function in Rat Models of 
Ischemia and Ischemia-Reperfusion
Bo-qing Zhu, John R. Teerlink, Joel S. Karliner, VA Medical Center, San Francisco, CA, 
University of California, San Francisco, San Francisco, CA
Background: The essential nutrient pyrroloquinoline quinone (PQQ) has been newly
identified as a redox cofactor vitamin for mammals. As PQQ has been shown to act as a
free radical scavenger, we asked if PQQ is cardioprotective in rat models of ischemia and
ischemia-reperfusion. Methods: Male Sprague-Dawley rats were treated with PQQ either
before ischemia (Group 1) or before ischemia-reperfusion (Group 2). PQQ (20 mg/kg)
was given 30 min before LAD occlusion by i.p. injection. Controls received vehicle (2%
NaHCO3 1ml). Rats in Group 1 were subjected to 2 hours of LAD ligation. Rats in Group
2 were subjected to 17 min of LAD occlusion and 2 hours of reperfusion with LV hemody-
namic monitoring using a Millar catheter. Results: In Group 1, infarct size (Infarct mass/
LV mass) after PQQ was smaller than Control (10.0±1.5 vs 19.1±2.1%, P<0.01). Group 2
data are shown the table. PQQ protected against ischemia-induced cardiac dysfunction
with higher LV+dP/dt and lower LV filling pressure (LVEDP) after 1 hour of reperfusion.
There were fewer episodes of ventricular fibrillation (VF) in PQQ treated rats. Another 3
sets of Group 2 rats (10 each) received 15, 10, and 5 mg/kg of PQQ. The dose of PQQ
was inversely related to infarct size (14±2, 22±2, 29±2%, P<0.01, respectively). Conclu-
sions: PQQ given as pretreatment is highly effective in reducing myocardial infarct size
and improving cardiac function in a dose-related manner in rat models of ischemia and
ischemia-reperfusion.
POSTER SESSION
1003 
Embolic Protection in Primary 
Angioplasty
Sunday, March 07, 2004, 9:00 a.m.-11:00 a.m.
Morial Convention Center, Hall G
Presentation Hour: 9:00 a.m.-10:00 a.m.
1003-85 Lack of Efficacy of Intracoronary Thrombus Aspiration 
Before Coronary Stenting in Patients With Acute 
Myocardial Infarction: A Multicenter Randomized Trial
Hiroyuki Kunii, Mikihiro Kijima, Takao Araki, Kenji Tamaki, Atsushi Katoh, Takaaki Kubo, 
Tomiyoshi Saitou, Akira Hirosaka, Hitoshi Matsuo, The NONSTOP Group, Iwaki Kyoritsu 
General Hospital, Iwaki, Japan
Background: Distal embolism of plaque or thrombotic debris is a major cause of no-
reflow or slow flow phenomena with primary stenting in patients with acute myocardial
infarction (AMI). Purpose: The aim of this study was to evaluate the safety and efficacy of
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3.5±0.5 3.6±0.3 18±4 17±2 90±9 96±7 2.1±0.4 35.5±2.8
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NS 0.049 NS 0.014 NS NS 0.017 <0.001
